Century Therapeutics Inc (IPSC) experienced a significant stock price surge of 20.74% on Wednesday, reaching $1.63 per share, its highest single-day jump in over 11 months. This surge follows Casdin Capital’s acquisition of an additional 1.38 million shares, increasing their stake in the biotechnology company by 43%. The investment highlights Casdin Capital’s confidence in Century Therapeutics’ future.
A high-profile court case has highlighted the urgency to establish a powerful new body that can discipline politicians and staff for serious misconduct in Australia’s Parliament House. The Independent Parliamentary Standards Commission (IPSC), as outlined in a leaked draft document, would have the authority to address offenses such as sexual assault, violence, and discrimination. The renewed push for the commission follows the recent verdict in the rape trial of former staffer Brittany Higgins, who was found to have been sexually assaulted in a ministerial office. Women’s Minister Katy Gallagher emphasized the ‘purpose and focus’ the ruling provides for swiftly implementing the IPSC, which was initially recommended in a 2021 report in response to Higgins’ allegations.
